Baumer et al., 2006 - Google Patents
Vascular endothelial cell–specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel developmentBaumer et al., 2006
View HTML- Document ID
- 9227397967893194503
- Author
- Baumer S
- Keller L
- Holtmann A
- Funke R
- August B
- Gamp A
- Wolburg H
- Wolburg-Buchholz K
- Deutsch U
- Vestweber D
- Publication year
- Publication venue
- Blood
External Links
Snippet
VE-PTP, a receptor-type phosphotyrosine phosphatase, associates with the tyrosine kinase receptor Tie-2 and VE-cadherin and enhances the adhesive function of the latter. Here, VE- PTP was found to be restricted to endothelial cells, with a preference for arterial …
- 210000002889 Endothelial Cells 0 title abstract description 52
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Baumer et al. | Vascular endothelial cell–specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development | |
| Park et al. | ALK5-and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2 | |
| Takahashi et al. | A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development | |
| Qu et al. | Abnormal embryonic lymphatic vessel development in Tie1 hypomorphic mice | |
| Trindade et al. | Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos | |
| AU763483B2 (en) | Artery- and vein-specific proteins and uses therefor | |
| Villefranc et al. | A truncation allele in vascular endothelial growth factor c reveals distinct modes of signaling during lymphatic and vascular development | |
| Hiratsuka et al. | Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice | |
| Nonaka et al. | Development of murine hepatic sinusoidal endothelial cells characterized by the expression of hyaluronan receptors | |
| US7939071B2 (en) | Artery- and vein-specific proteins and uses therefor | |
| Ye et al. | Genetic mosaic analysis reveals a major role for frizzled 4 and frizzled 8 in controlling ureteric growth in the developing kidney | |
| Lacko et al. | Altered feto-placental vascularization, feto-placental malperfusion and fetal growth restriction in mice with Egfl7 loss of function | |
| Chang et al. | Pbx1 functions in distinct regulatory networks to pattern the great arteries and cardiac outflow tract | |
| US20070148706A1 (en) | Pancreatic progenitor cells and methods for isolating the same | |
| Richarte et al. | Cooperation between the PDGF receptors in cardiac neural crest cell migration | |
| Inman et al. | Brachyury is required for elongation and vasculogenesis in the murine allantois | |
| Kuhnert et al. | Dosage-dependent requirement for mouse Vezf1 in vascular system development | |
| Stenzel et al. | Peripheral mural cell recruitment requires cell-autonomous heparan sulfate | |
| Li-Villarreal et al. | FOXO1 represses sprouty 2 and sprouty 4 expression to promote arterial specification and vascular remodeling in the mouse yolk sac | |
| Morooka et al. | Angpt1 binding to Tie1 regulates the signaling required for lymphatic vessel development in zebrafish | |
| Luxey et al. | Generation of transgenic mice overexpressing EfnB2 in endothelial cells | |
| Murayama et al. | Alcam-a and Pdgfr-α are essential for the development of sclerotome derived stromal cells that support hematopoiesis in vivo | |
| Wang | The cell autonomous and cell non-automous roles of YAP1 during pancreatogenesis | |
| Labbé | Identification of factors regulating the brain angiogenesis and blood-brain barrier formation | |
| Tung | Evaluation of Chloride Intracellular Channels 4 and 1 Functions in Developmental and Pathological Angiogenesis |